Get started
Author

Koji Shiraishi

ORCID: 0000-0002-3278-7747
Observed ORCID: 0000-0002-3278-7747
OpenAlex ID: A5111636090
Inhibition of Calpain but Not Caspase Protects the Testis Against Injury after Experimental Testicular Torsion of Rat
2000 · Koji Shiraishi, Katsusuke Naito, et al. · Biology of Reproduction · 33
Mesoblastic nephroma in adulthood: A case report
1999 · Koji Shiraishi, Mitsutaka Yamamoto, et al. · International Journal of Urology · 12
Long-Term Outcomes of Varicocelectomy in Children and Adolescents: Impact of Timing on Testicular Growth and Spermatogenesis
2026 · Koji Shiraishi, Satoshi Tokitaka, et al. · The Journal of Urology · 5
Idiopathic Clitoral Hypertrophy
1999 · Koji Shiraishi, Kazuhiko Ishizu, et al. · Urologia Internationalis · 5
Prognostic Significance of Pretreatment Blood‐Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan
2026 · Shuichi Tatarano, Makito Miyake, et al. · International Journal of Urology · 4
Refining the CHAARTED Classification: Clinical Utility of a Novel Integrated Risk Stratification Model Incorporating Gleason Grade and Biochemical Markers in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer
2025 · Takanori Tokunaga, Keita Kobayashi, et al. · The Prostate · 4
Prognostic value of the postoperative CALLY index in T1/T2 clear cell renal cell carcinoma
2025 · Hiroshi Hirata, Nakanori Fujii, et al. · Oncology Letters · 3
PDF
Comprehensive Evaluation of Androgen Receptor Pathway Inhibitors in Metastatic Castration-Sensitive Prostate Cancer: A Multicenter Inverse Probability of Treatment Weighting-Based Study
2025 · Keita Kobayashi, Takanori Tokunaga, et al. · Clinical Genitourinary Cancer · 3
PDF
Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC
2025 · Yoichiro Tohi, Keita Kobayashi, et al. · Japanese Journal of Clinical Oncology · 2
PDF
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxel
2026 · Takuma Kato, Yoichiro Tohi, et al. · International Journal of Clinical Oncology · 1
Long non-coding RNA PSMB8-AS1 as a potential biomarker for postoperative recurrence in patients with Fuhrman grades 1–3 clear cell renal cell carcinoma
2026 · Chieko Baba, Hiroshi Hirata, et al. · PLoS ONE · 1
PDF
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan
2026 · Keita Kobayashi, Kei Daizumoto, et al. · International Journal of Urology · 1
The Pretreatment Neutrophil-to-Eosinophil Ratio Can Predict Immune-Related Adverse Events and Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
2025 · Keita Kobayashi, Shigeru Sakano, et al. · Cureus · 1
Time to Prostate‐Specific Antigen Failure as a Unique Prognosticator of Overall Survival in Biochemically Recurrent Prostate Cancer Patients Undergoing Radical Prostatectomy
2025 · Tomoyuki Shimabukuro, Takanori Tokunaga, et al. · Advances in Urology · 1
PDF
Prophylactic intravenous dexamethasone is associated with reduced cutaneous toxicity during first-line enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma: a multicenter prospective cohort study
2026 · Rikiya Taoka, Keita Tamura, et al. · International Journal of Clinical Oncology
Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective Study
2026 · Ryutaro Shimizu, Shuichi Morizane, et al. · Nutrition and Cancer
Pediatric andrology: bridging pediatric urology and reproductive medicine
2026 · Koji Shiraishi · Current Opinion in Urology
Reply by Authors
2026 · Koji Shiraishi, Satoshi Tokitaka, et al. · The Journal of Urology
Real‐World Impact of Androgen Deprivation Therapy Intensification on Prostate Cancer Outcome: A Propensity Score‐Matched Analysis From a 25‐Year Institutional Experience
2026 · Tomoyuki Shimabukuro, Chietaka Ohmi, et al. · Advances in Urology
Prognostic nutritional index predicts the prognostic impact of avelumab maintenance therapy in patients with advanced urothelial carcinoma: results from the Chu-shikoku Japan Urological Consortium
2025 · Hideo Fukuhara, Shingo Nishimura, et al. · Japanese Journal of Clinical Oncology
IP21-26 DIAGNOSTIC UTILITY OF α2,3-SIALYLATED PROSTATE-SPECIFIC ANTIGEN FOR PROSTATE CANCER DETECTION: A PROSPECTIVE OBSERVATIONAL STUDY IN PATIENTS WITH PSA LEVELS OF 4-20 ng/mL
2025 · Takanori Tokunaga, Koichiro Hiyoshi, et al. · The Journal of Urology
PDF
Works count: 21
Citation count: 76
H-index: 4
I10-index: 2
Year
Topic
Type